
The Food and Drug Administration (FDA) has revoked its approval for two Covid-19 antibody drugs that don’t work against the highly transmissible Omicron variant.
Omicron now makes up almost all new infections in the US, with the FDA announcing on Monday that they were pulling their emergency authorisation for the antibody drugs from Regeneron and Eli Lilly.